Summary:
The purpose of the study is to find out if the study drug that is being studied, is safe and effective in treating adults like you who have moderate to severe hidradenitis suppurativa.
Qualified Participants Must:
• 18-70 years old
• Have HS >6 months
• HS has not responded well to antibiotics: be willing to commit to 13 office visits over 45 weeks